1. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma
   Fei Feng et al, 2017, Cancer Biology & Therapy CrossRef
2. Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter-based drug-drug interactions
   Jannick Clemens et al, 2017 CrossRef
3. Nell-1-ΔE, a novel transcript of Nell-1, inhibits cell migration by interacting with enolase-1
   Huaxiang Zhao et al, 2018, J. Cell. Biochem. CrossRef
4. Anticancer, antimicrobial, and DNA protection analysis of novel 2,4-dihydroxyquinoline dyes
   Nesrin Şener et al, 2018, Dyes and Pigments CrossRef
5. A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis.
   Azmi Yerlikaya, 0 CrossRef
6. Investigations into the therapeutic potential of Asphodeline liburnica roots: In vitro and in silico biochemical and toxicological perspectives
   Marcello Locatelli et al, 2018, Food and Chemical Toxicology CrossRef
7. Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer.
   Nirmish Singla et al, 2019, Expert Opin Investig Drugs CrossRef
8. PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance.
   Zhenrui Fu et al, 2019, Anticancer Drugs CrossRef
9. Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line.
   Azmi Yerlikaya, 0 CrossRef
10. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF-Mediated EZH2/VASH1 Pathway
    Bin Huang et al, 2019, Technol Cancer Res Treat CrossRef
11. An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line.
    Azmi Yerlikaya, 0 CrossRef
12. Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity
    Nicholas Sciascia et al, 2020 CrossRef
13. Novel water soluble Schiff base metal complexes: Synthesis, characterization, antimicrobial-, DNA cleavage, and anticancer activity
    C. Shiju et al, 2020, Journal of Molecular Structure CrossRef
14. The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor
    Kenji Kuroda et al, 2019, Int J Oncol CrossRef
15. Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro
    Sarah E. Kohrt et al, 2021, Mol Cancer Ther CrossRef
16. The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells.
    Azmi Yerlikaya, 0 CrossRef
17. Synthesis, characterization, and anticancer activity of some metal complexes with a new Schiff base ligand
    Thamer A. Alorini et al, 2022, Arabian Journal of Chemistry CrossRef
18. P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors
    Andressa Barban do Patrocinio et al, 2022, ACS Omega CrossRef
19. Elaboration of novel urea bearing schiff bases as potent in vitro anticancer candidates with low in vivo acute oral toxicity
    Lotfi M. Aroua et al, 2022, MGC CrossRef
20. Cytotoxic urea Schiff base complexes for multidrug discovery as anticancer activity and low in vivo oral assessing toxicity
    Lotfi M. Aroua et al, 2022, Arabian Journal of Chemistry CrossRef
21. Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Cytotoxic and Genotoxic Activities In Vitro
    Karol Bukowski et al, 2022, Molecules CrossRef
22. The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
    Lei Zhang et al, 2022, PRA CrossRef
23. Selagibenzophenone B and Its Derivatives: SelB-1, a Dual Topoisomerase I/II Inhibitor Identified through In Vitro and In Silico Analyses
    Serhat Dönmez et al, 2024, ACS Bio Med Chem Au CrossRef
24. Advancement in schiff base complexes for treatment of colon cancer
    Afaf Murtadha Kadhum et al, 2024 CrossRef
25. Noncanonical inhibition of topoisomerase II alpha by oxidative stress metabolites
    Amy C. Flor et al, 2025, Redox Biology CrossRef